Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IT'S PREMATURE!

Re: IT'S PREMATURE! NOT!

posted on Jan 08, 2009 09:45AM

I didn't read all the RS nonsense because it's not applicable at this time. Maybe down the road?



If the Board are discussing it, at this moment in time, how is it premature for shareholders to do the same?



2)What are our current thoughts on pursuing a NASDAQ listing?

One of the Company’s objectives is to pursue, at the right time, a listing on a more broadly traded exchange, probably NASDAQ. During my last trip to New York City I had the opportunity to meet with the NASDAQ representative for new listings and discussed the prospects for Patriot. Based on the current listing criteria NASDAQ has established, Patriot could pursue listing on NASDAQ’s Global Market if we met the share price criteria. All other capital and financial requirements can be met. Therefore, the decision to pursue a NASDAQ, or other exchange, listing, is not if, but when.

As I’m sure you can appreciate, Patriot’s management and the Board are keenly sensitive to the concerns of the shareholders with respect to share price and the potential for a reverse split of Patriot shares. There is no discussion to pursue a reverse split under the current market conditions, however, I have begun dialogue with the Board about the conditions, both internal and external, which would serve as a trigger to launch the process.

We believe that it will be in the best long term interest of shareholders to seek listing on a more broadly traded exchange, but do not feel that current business conditions warrant active pursuit of this goal today.

http://patriotscientific.com/index.p...



The question remains, at what price will there be a split and at what ratio?

Not if, but when.





Be well





Share
New Message
Please login to post a reply